biotickrEntheon Biomedical Corp
The ENTBF stock trades on Otc Markets
Company Description
Entheon Biomedical Corp. operates as a biotechnology research and development company. The Company focuses on developing and commercializing dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. Entheon Biomedical serves clients worldwide.
Drug Pipeline
Source: Entheon Biomedical Corp - 20220925
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
EBIQ-101
Addiction
Preclinical
EBRX-101
Addiction
Phase 1
0 Comments on ENTBF stock
Newest
Conversation